658 results Stibbe advises Advantest Corporation on the acquisition of Salland Engineering Stibbe has successfully assisted Advantest Corporation in their acquisition of Salland Engineering. Under this acquisition, Salland Engineering will be an independent, wholly-owned (indirect) subsidiary of Advantest Europe GmbH. Stibbe advises Abab and Alfa on merger Stibbe has successfully assisted ‘ABAB Accountants’ and ‘Alfa Accountants en Adviseurs’ in their merger process. ESMA guidance on pre-close calls with analysts ESMA issued a statement on the practice of organising pre-close calls, where issuers share information with analysts immediately before a closed period. ESMA reiterates the legislative framework and identifies best practices for these calls. Key Insights Stibbe Capital Markets Seminar 2024 The focus of this year's annual Capital Markets Seminar, attended by over 70 capital markets participants, was on "The case for Amsterdam listings - now and in the future". Read here the key insights. Stibbe Amsterdam appoints two new counsel We are pleased to announce that Stibbe Amsterdam has promoted Rut Molenaar-Wingens and Phinney Disseldorp to counsel effective 1 July and 1 August. Klachtplicht niet van toepassing bij overtreding concurrentiebeding (annotatie) Het oordeel van de Hoge Raad dat de klachtplicht ex artikel 6:89 BW niet van toepassing is bij schending van een concurrentiebeding sluit aan bij eerdere rechtspraak. Stibbe advises ING Belgium on the placement of shares of Xior Student Housing to Katoen-Natie Group Stibbe advised ING Belgium on the €80 million placement of 6.5% of all shares of Xior Student Housing. Max Joosten Junior Associate Brussels Esther Schrijvers Junior Associate Brussels Stan Bruurs Junior Associate Brussels Yasmin Farzanh Junior Associate Amsterdam Sterre Thijssen Junior Associate Amsterdam AFM review indicates lack of transparency in use of alternative performance measures by Dutch issuers AFM sets out the findings of its review of the use of alternative performance measures in financial reporting and concludes that Dutch issuers often fall short of the required level of transparency when reporting their alternative performance measures. De Wtta part II: invulling van het normenkader, maar nog steeds (veel) onduidelijkheid In een eerdere bijdrage hebben wij het Wetsvoorstel toelating terbeschikkingstelling van arbeidskrachten (de Wtta) besproken. Egbert Vroom Partner Amsterdam Modernisering van het concurrentiebeding: enkele vragen en antwoorden In het recent ter consultatie voorgelegde concept Wetsvoorstel modernisering concurrentiebeding (het “Voorstel”) worden de regels die gelden voor het concurrentiebeding (artikel 7:653 BW) aangescherpt. Stibbe advises GRW on the acquisition of Van Hool’s industrial vehicle division Stibbe advised GRW, the South African tanker and trailer manufacturer allied with Schmitz Cargobull, on acquiring the industrial vehicle division of Van Hool, following the latter’s declaration of bankruptcy. Stibbe advises Goed A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business. Pagination Previous page Page 12 Current page 13 Page 14 Page 15 Next page
Stibbe advises Advantest Corporation on the acquisition of Salland Engineering Stibbe has successfully assisted Advantest Corporation in their acquisition of Salland Engineering. Under this acquisition, Salland Engineering will be an independent, wholly-owned (indirect) subsidiary of Advantest Europe GmbH.
Stibbe advises Abab and Alfa on merger Stibbe has successfully assisted ‘ABAB Accountants’ and ‘Alfa Accountants en Adviseurs’ in their merger process.
ESMA guidance on pre-close calls with analysts ESMA issued a statement on the practice of organising pre-close calls, where issuers share information with analysts immediately before a closed period. ESMA reiterates the legislative framework and identifies best practices for these calls.
Key Insights Stibbe Capital Markets Seminar 2024 The focus of this year's annual Capital Markets Seminar, attended by over 70 capital markets participants, was on "The case for Amsterdam listings - now and in the future". Read here the key insights.
Stibbe Amsterdam appoints two new counsel We are pleased to announce that Stibbe Amsterdam has promoted Rut Molenaar-Wingens and Phinney Disseldorp to counsel effective 1 July and 1 August.
Klachtplicht niet van toepassing bij overtreding concurrentiebeding (annotatie) Het oordeel van de Hoge Raad dat de klachtplicht ex artikel 6:89 BW niet van toepassing is bij schending van een concurrentiebeding sluit aan bij eerdere rechtspraak.
Stibbe advises ING Belgium on the placement of shares of Xior Student Housing to Katoen-Natie Group Stibbe advised ING Belgium on the €80 million placement of 6.5% of all shares of Xior Student Housing.
AFM review indicates lack of transparency in use of alternative performance measures by Dutch issuers AFM sets out the findings of its review of the use of alternative performance measures in financial reporting and concludes that Dutch issuers often fall short of the required level of transparency when reporting their alternative performance measures.
De Wtta part II: invulling van het normenkader, maar nog steeds (veel) onduidelijkheid In een eerdere bijdrage hebben wij het Wetsvoorstel toelating terbeschikkingstelling van arbeidskrachten (de Wtta) besproken.
Modernisering van het concurrentiebeding: enkele vragen en antwoorden In het recent ter consultatie voorgelegde concept Wetsvoorstel modernisering concurrentiebeding (het “Voorstel”) worden de regels die gelden voor het concurrentiebeding (artikel 7:653 BW) aangescherpt.
Stibbe advises GRW on the acquisition of Van Hool’s industrial vehicle division Stibbe advised GRW, the South African tanker and trailer manufacturer allied with Schmitz Cargobull, on acquiring the industrial vehicle division of Van Hool, following the latter’s declaration of bankruptcy.
Stibbe advises Goed A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business.